[HTML][HTML] A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
…, SK Kjaer, OM Bautista, ISF Chan, J Chen… - … England Journal of …, 2015 - Mass Medical Soc
Background The investigational 9-valent viruslike particle vaccine against human papillomavirus
(HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6, 11, 16, and …
(HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6, 11, 16, and …
[HTML][HTML] Raltegravir with optimized background therapy for resistant HIV-1 infection
…, A Lazzarin, B Clotet, J Zhao, J Chen… - … England Journal of …, 2008 - Mass Medical Soc
Background Raltegravir (MK-0518) is an inhibitor of human immunodeficiency virus type 1 (HIV-1)
integrase active against HIV-1 susceptible or resistant to older antiretroviral drugs. …
integrase active against HIV-1 susceptible or resistant to older antiretroviral drugs. …
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised …
…, A Lazzarin, D Vittecoq, CJ Gonzalez, J Chen… - The Lancet, 2007 - thelancet.com
Background Raltegravir (MK-0518) is an HIV-1 integrase inhibitor with potent in-vitro activity
against HIV-1 strains including those resistant to currently available antiretroviral drugs. The …
against HIV-1 strains including those resistant to currently available antiretroviral drugs. The …
[HTML][HTML] Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection
Background We evaluated the efficacy of raltegravir and the development of viral resistance
in two identical trials involving patients who were infected with human immunodeficiency …
in two identical trials involving patients who were infected with human immunodeficiency …
[HTML][HTML] A wireless millimetric magnetoelectric implant for the endovascular stimulation of peripheral nerves
Implantable bioelectronic devices for the simulation of peripheral nerves could be used to
treat disorders that are resistant to traditional pharmacological therapies. However, for many …
treat disorders that are resistant to traditional pharmacological therapies. However, for many …
[PDF][PDF] Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial
TA Le, J Chen, C Changchien, MR Peterson… - …, 2012 - Wiley Online Library
Bile acid sequestrants (BAS) lower plasma low density lipoprotein levels and improve glycemic
control. Colestimide, a BAS, has been claimed by computed tomography to reduce liver …
control. Colestimide, a BAS, has been claimed by computed tomography to reduce liver …
Self-rectifying magnetoelectric metamaterials for remote neural stimulation and motor function restoration
Magnetoelectric materials convert magnetic fields into electric fields. These materials are
often used in wireless electronic and biomedical applications. For example, magnetoelectrics …
often used in wireless electronic and biomedical applications. For example, magnetoelectrics …
Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase
Objective: Raltegravir (MK-0518) belongs to the new class of HIV integrase inhibitors. To
date, there have been no reports investigating the potential for differential effects on viral …
date, there have been no reports investigating the potential for differential effects on viral …
[PDF][PDF] TikTok and its role in COVID-19 information propagation
AM Ostrovsky, JR Chen - Journal of adolescent health, 2020 - researchgate.net
The coronavirus disease 2019 (COVID-19) pandemic generated the near-complete closure
of US educational institutions during the Spring 2020 semester, affecting approximately 55.1 …
of US educational institutions during the Spring 2020 semester, affecting approximately 55.1 …
Immunogenicity and safety of a 9-valent HPV vaccine
…, LM Huang, DS Kim, P Pitisuttithum, J Chen… - …, 2015 - publications.aap.org
OBJECTIVES: Prophylactic vaccination of youngwomen aged 16 to 26 years with the 9-valent
(6/11/16/18/31/33/45/52/58) human papillomavirus (HPV) virus-like particle (9vHPV) …
(6/11/16/18/31/33/45/52/58) human papillomavirus (HPV) virus-like particle (9vHPV) …